Infinity Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme …

Biotechnology
US, Cambridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of INFI's Analysis
CIK: 1113148 CUSIP: 45665G303 ISIN: US45665G3039 LEI: - UEI: -
Secondary Listings
INFI has no secondary listings inside our databases.